RESI Boston, Sept. 21-23
RESI connects start-ups, early-stage investors, and strategic channel partners maximizing fit for each technology and each company’s stage of development.
Author Archive for: ayal
Entries by Ayal Ronen
MedFIT, Sept. 21-22, Grenoble, France
As a leading European partnering event, with 700+ participants from 30+ countries, MedFIT helps industry players find early-stage assets…
LSX Nordic Congress, Sept. 2022 (Copenhagen)
senior executive conference advancing healthcare by connecting leaders in science and industry with investors and strategic partners
Kisaco Onco Cell Therapy Summit, June 29-30, 2022 (Boston)
How to Deliver Safe and Effective Adoptive Cell Therapy Products to Clinical Promise, Commercial Scale Manufacturing and Patients
Immuno-Oncology Innovation Forum, May 24-25, 2022 (online)
The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharmas, & biotechs. 300+, 20+ company presentations, 50+% attendees are corporate and financial investors, analysts, bankers and advisors.
Digital RESI, June 7-9, 2022 (online)
Your opportunity to connect with investors and strategic partners, Digital RESI June focuses on early-stage funding for all life science verticals: drugs, devices, diagnostics, digital health.
LSX World Congress USA, June 21-22, 2022 (Boston)
LSX is an community of senior life science & healthcare decision-makers that develops connections with the capital and partners we need to grow our businesses.
Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
NCI and CDMRP are awarding over $7 BILLION in funding for cancer R&D. To learn more, listen to our free webinar about these opportunities.
Cancer Research in 2022: More than $7 Billion in Funding Opportunities
Find out about more than $7 Billion In Funding Opportunities for Cancer Research – and our webinar all about them
$130 Million in Funding Opportunities from PRCRP
The Peer Reviewed Cancer Research Program (PRCRP) of the Congressionally Directed Medical Research Programs (CDMRP) has just announced $130 million in funding opportunities for fiscal year 2022.